PDCD1 and neoplasm: Consistent with these findings, tumor weight measurements showed that Myeloid-GAS6 KO mice had smaller tumors than WT mice, and α-PD-1 treatment further reduced tumor burden, with the most pronounced effect observed in Myeloid-GAS6 KO mice (Fig. 8C).